Single-blind Randomised Pragmatic Trial Comparing the Effectiveness of Two Hyaluronic Acid Viscosupplements, DUROLANE (Single Injection) Versus HYALGAN (Three Injections) for Symptomatic Tibiofemoral Osteoarthritis of the Knee.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Hyaluronic acid (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 12 Feb 2016 Biomarkers information updated
- 11 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov.
- 11 Jul 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.